Table 2 Characteristics of the sample according to the use of statins
|  | Not medicated with statins (n = 47) | Statin users (n = 89) | p-value |
|---|---|---|---|
Sex, n (%) | Â | Â | 0.237 |
 Women | 19 (40.4) | 27 (30.3) |  |
 Men | 28 (56.9) | 62 (67.7) |  |
Age, years, Md (IQR) | 51.0 (39.0, 64.0) | 62.0 (54.0, 69.0) |  < 0.001 |
Age categories, n (%) | Â | Â | 0.025 |
  < 65 years | 37 (78.7) | 53 (59.6) |  |
  ≥ 65 years | 10 (21.3) | 36 (40.4) |  |
HF aetiology, n (%) |  |  |  < 0.001 |
 Dilated cardiomyopathy | 29 (61.7) | 43 (48.3) |  |
 Ischaemic* | 4 (8.5) | 34 (38.2) |  |
 Myocarditis* | 4 (8.5) | 1 (1.1) |  |
 Hypertrophic cardiomyopathy | 4 (8.5) | 5 (5.6) |  |
 Others | 6 (12.8) | 6 (6.7) |  |
LVEF categories, n (%) | Â | Â | 0.404 |
 HFrEF + HFmrEF | 36 (78.3) | 63 (71.6) |  |
 HFpEF | 10 (21.7) | 25 (28.4) |  |
NYHA classification, n (%) | Â | Â | 0.455 |
 Class I | 16 (34.8) | 31 (35.2) |  |
 Class II | 20 (43.5) | 45 (51.1) |  |
 Class III | 10 (21.7) | 12 (13.6) |  |
Incident myocardial infarction, n (%) | 2 (4.5) | 30 (33.7) |  < 0.001 |
Polypharmacy, n (%) | 25 (54.3) | 76 (85.4) |  < 0.001 |
Type 2 Diabetes Mellitus | 9 (19.6) | 30 (33.7) | 0.086 |
Number of medicines/day, Md (IQR) | 5.0 (3.8, 8.0) | 7.0 (5.5, 9.5) |  < 0.001 |
Physical activity, n (%) | Â | Â | 0.175 |
 Inactive | 30 (63.8) | 46 (51.7) |  |
 Minimally active + active | 17 (36.2) | 43 (48.3) |  |
Body Mass Index, Kg.m−2, M (SD) | 28.9 (4.7) | 29.4 (4.2) | 0.526 |
Fat intake, g/day, Md (IQR) | 59.7 (47.5, 86.4) | 54.1 (37.0, 74.4) | 0.149 |